Little is known about the new subvariant, however, it appears to be highly transmissible, much like.
Following the booster, the vaccine was estimated to prevent 92 percent of hospitalizations, and remains effective more than 10 weeks after, as it proved to be 83 percent effective, according to the study.
This could be a bacterial infection, which requires immediate medical intervention.